MSC-induced lncRNA AGAP2-AS1 promotes stemness and trastuzumab resistance through regulating CPT1 expression and fatty acid oxidation in breast cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MSC-induced lncRNA AGAP2-AS1 promotes stemness and trastuzumab resistance through regulating CPT1 expression and fatty acid oxidation in breast cancer
Authors
Keywords
-
Journal
ONCOGENE
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-12-04
DOI
10.1038/s41388-020-01574-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ZEB1 induced‐upregulation of long noncoding RNA ZEB1‐AS1 facilitates the progression of triple negative breast cancer by binding with ELAVL1 to maintain the stability of ZEB1 mRNA
- (2020) Na Luo et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Exosome-mediated lncRNA AFAP1-AS1 promotes trastuzumab resistance through binding with AUF1 and activating ERBB2 translation
- (2020) Mingli Han et al. Molecular Cancer
- MSC-induced lncRNA HCP5 drove fatty acid oxidation through miR-3619-5p/AMPK/PGC1α/CEBPB axis to promote stemness and chemo-resistance of gastric cancer
- (2020) Honglei Wu et al. Cell Death & Disease
- FoxM1-dependent and fatty acid oxidation-mediated ROS modulation is a cell-intrinsic drug resistance mechanism in cancer stem-like cells
- (2020) Hae-Ji Choi et al. Redox Biology
- RREB1-induced upregulation of the lncRNA AGAP2-AS1 regulates the proliferation and migration of pancreatic cancer partly through suppressing ANKRD1 and ANGPTL4
- (2019) Bingqing Hui et al. Cell Death & Disease
- MSC-regulated lncRNA MACC1-AS1 promotes stemness and chemoresistance through fatty acid oxidation in gastric cancer
- (2019) Wanming He et al. ONCOGENE
- Comprehensive analysis of a ceRNA network reveals potential prognostic cytoplasmic lncRNAs involved in HCC progression
- (2019) Yi Bai et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma
- (2019) Zhikui Liu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer
- (2019) Edith A. Perez et al. BMC CANCER
- Potential Biomarker and Therapeutic LncRNAs in Multiple Sclerosis Through Targeting Memory B Cells
- (2019) Elahe Ghoveud et al. NEUROMOLECULAR MEDICINE
- LncRNA SPRY4‐IT1 regulates breast cancer cell stemness through competitively binding miR‐6882‐3p with TCF7L2
- (2019) Xinyue Song et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Telomere-associated genes and telomeric lncRNAs are biomarker candidates in lung squamous cell carcinoma (LUSC)
- (2019) Camila Baldin Storti et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- LncRNA HOXB‐AS1 promotes cell growth in multiple myeloma via FUT4 mRNA stability by ELAVL1
- (2019) Rongsheng Chen et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Global burden of breast cancer and attributable risk factors in 195 countries and territories, from 1990 to 2017: results from the Global Burden of Disease Study 2017
- (2019) Na Li et al. Journal of Hematology & Oncology
- Long non-coding RNA UCA1 desensitizes breast cancer cells to trastuzumab by impeding miR-18a repression of Yes-associated protein 1
- (2018) Hua-yu Zhu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The AU-rich element landscape across human transcriptome reveals a large proportion in introns and regulation by ELAVL1/HuR
- (2018) Tala Bakheet et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- The Impact of lncRNA Dysregulation on Clinicopathology and Survival of Breast Cancer: A Systematic Review and Meta-analysis
- (2018) Tian Tian et al. Molecular Therapy-Nucleic Acids
- Exosome-mediated transfer of lncRNA PART1 induces gefitinib resistance in esophageal squamous cell carcinoma via functioning as a competing endogenous RNA
- (2018) Min Kang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88
- (2018) Huaying Dong et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Immunoregulatory protein B7-H3 regulates cancer stem cell enrichment and drug resistance through MVP-mediated MEK activation
- (2018) Zixing Liu et al. ONCOGENE
- Expression Analysis of MALAT1, GAS5, SRA, and NEAT1 lncRNAs in Breast Cancer Tissues from Young Women and Women over 45 Years of Age
- (2018) Asghar Arshi et al. Molecular Therapy-Nucleic Acids
- Identification of functional lncRNAs in atrial fibrillation by integrative analysis of the lncRNA-mRNA network based on competing endogenous RNAs hypothesis
- (2018) Cheng Qian et al. JOURNAL OF CELLULAR PHYSIOLOGY
- lncRNA profile study reveals the mRNAs and lncRNAs associated with docetaxel resistance in breast cancer cells
- (2018) Peide Huang et al. Scientific Reports
- iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
- (2017) Lesley Seymour et al. LANCET ONCOLOGY
- Histone code and long non-coding RNAs (lncRNAs) aberrations in lung cancer: implications in the therapy response
- (2017) Abril Marcela Herrera-Solorio et al. Clinical Epigenetics
- Annexin A2 and its downstream IL-6 and HB-EGF as secretory biomarkers in the differential diagnosis of Her-2 negative breast cancer
- (2016) Praveenkumar Shetty et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of FcγRIIIA/FcγRIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines
- (2015) Silvia Boero et al. Journal of Translational Medicine
- LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer
- (2015) Sheng-Jia Shi et al. Oncotarget
- MSC-Regulated MicroRNAs Converge on the Transcription Factor FOXP2 and Promote Breast Cancer Metastasis
- (2014) Benjamin G. Cuiffo et al. Cell Stem Cell
- Multiple drug resistance due to resistance to stem cells and stem cell treatment progress in cancer (Review)
- (2014) CHONG DI et al. Experimental and Therapeutic Medicine
- Trastuzumab emtansine in the treatment of HER-2-positive metastatic breast cancer patients
- (2013) Claudia Bighin et al. Future Oncology
- Potential biomarkers of long-term benefit from single-agent trastuzumab or lapatinib in HER2-positive metastatic breast cancer
- (2013) Filippo Montemurro et al. Molecular Oncology
- starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq data
- (2013) Jun-Hao Li et al. NUCLEIC ACIDS RESEARCH
- Increased signalling of EGFR and IGF1R and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas
- (2012) A Gallardo et al. BRITISH JOURNAL OF CANCER
- Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
- (2012) Sunil Verma et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer drug pan-resistance: pumps, cancer stem cells, quiescence, epithelial to mesenchymal transition, blocked cell death pathways, persisters or what?
- (2012) P. Borst Open Biology
- ViennaRNA Package 2.0
- (2011) Ronny Lorenz et al. Algorithms for Molecular Biology
- A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancer
- (2011) D. Amadori et al. EUROPEAN JOURNAL OF CANCER
- Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells
- (2010) Lisa S. Pike et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Comparison of six bone-graft substitutes regarding to cell seeding efficiency, metabolism and growth behaviour of human mesenchymal stem cells (MSC) in vitro
- (2010) Caroline Seebach et al. INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED
- The role of HER2 in early breast cancer metastasis and the origins of resistance to HER2-targeted therapies
- (2009) Jaclyn A. Freudenberg et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started